Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery

British Journal of Surgery

Volumn 75, Issue 11, 1988, Pages 1058-1063

  Encke, A ^a   Breddin, K ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

125I labelled fibrinogen leg scanning; abdominal surgery; Fraxiparin ; heparin; Low molecular weight heparin; pulmonary embolism; thrombosis prevention; vein thrombosis

Indexed keywords

HEPARIN CALCIUM; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ABDOMINAL SURGERY; ADULT; AGE; CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ABDOMEN; AGED; CLINICAL TRIALS; CLOTHING; COMPARATIVE STUDY; FEMALE; HEMORRHAGE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMAN; MALE; MIDDLE AGE; MULTICENTER STUDIES; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RANDOM ALLOCATION; THROMBOPHLEBITIS;

EID: 0023761779     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.1800751105     Document Type: Article

References (30)

1. Low‐molecular‐weight heparin and prevention of postoperative deep vein thrombosis
2. Clinical efficacy of low molecular weight heparin in postoperative thrombosis prophylaxis
3. Efficacy and safety of low‐molecular‐weight heparin (CY 216) in preventing postoperative venous thrombo‐embolism: a co‐operative study
4. Low molecular weight heparin once a day compared with conventional low dose heparin. A prospective double‐blind multicentre trial on prevention of postoperative thrombosis
5. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis
6. Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery
7. A randomized controlled trial of a low‐molecular‐weight heparin (Enoxaparin) to prevent deep‐vein thrombosis in patients undergoing elective hip surgery
8. Development of heparin fractions: Some overlooked considerations
9. Bioavailability and antagonization of the low molecular weight heparin CY 216 in man
10. Molecular weight dependence in the anticoagulant properties of heparin: intravenous and subcutaneous administration of fractionated heparins to man
11. Anticoagulant and anti‐thrombotic effects of heparin and low molecular weight heparin fragments in rabbits
12. Effect of heparin and heparin fractions on platelet aggregation
13. An objective assessment of the interaction of heparin and its fractions with human platelets
14. Rationale behind the development of low molecular weight heparin derivatives
15. Heparin and low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis
16. Studies on the profibrinolytic actions of heparin and its fractions
17. Comparison of the haemorrhagic effects of unfractionated heparin and a low molecular weight heparin fraction (CY 216) in rabbits
18. Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin
19. Prevention of fatal postoperative pulmonary embolism by low doses of heparin
20. Plasma heparin: a unique, practical, submicrogram‐sensitive assay
21. 125I‐labelled fibrinogen test adapted for routine screening for deep‐vein thrombosis
22. Prophylaxe der tiefen Venenthrombosen und Lungenembolien in der Chirurgie
23. Incidences of fatal postoperative pulmonary embolism after prophylaxis with dextran 70 and low‐dose heparin: an international multi‐center study
24. Heparin‐induced increase in serum levels of aminotransferases
25. Low molecular weight heparin: is small beautiful?
26. The development of low molecular weight heparins for clinical use
27. Dihydroergotamin‐heparin prophylaxis of postoperative deep vein thrombosis, a multicenter trial
28. A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation
29. A comparative study on the in vitro and in vivo activities of seven low molecular weight heparins